CNMV Communications | Almirall

Dermatology

• Atopic dermatitis
• Psoriasis
• Actinic keratosis
• Acne
• Other skin conditions
  • Onychomycosis
  • Alopecia areata
  • Keratinocyte cancer
  • Vitiligo
  • Hidradenitis suppurativa
  • Rare skin diseases

CNMV communications

The significant events included in this section are those submitted to the National Exchange Commission (CNMV), the Spanish securities market regulator, and can be consulted on the official CNMV website.

Investors

Stock information

• Share performance
• Share capital & ownership
  • Share and capital structure
  • Share issues
  • Shareholdings
• Analyst coverage
• Corporate actions & financing
  • Takeover bids
  • Dividends
  • Debt issues

Financial data

• Financial results and accounts
• Public periodic information
• Financial information materials
  • Financial data
  • Factsheet
  • Corporate presentations
  • Average period of payment to suppliers

Other relevant information

Significant events

• H1 2026 Financial Results presentation (23 July 2026)
• Webcast with analysts and institutional investors H1 2026 (23 July 2026)
• Almirall divests its Actithiol franchise (29 June 2026)
• Information on dividend (3 June 2026)
• Almirall S.A. announces information related to the Flexible Dividend (10 May 2026)
• Q1 2026 Financial Results presentation (10 May 2026)
• Webcast with analysts and institutional investors Q1 2026 (10 May 2026)
• Resolutions adopted in the Ordinary General Meeting of Almirall (10 May 2026)
• Resolutions adopted by the Board of Directors (10 May 2026)
• Almirall S.A. announces information related to the Flexible Dividend (10 May 2026)